Intuitive Surgical controller sells 5,448 shares
The sale comprised multiple transactions priced from $431.64 to $453.60, under a plan that expires September 15, 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Intuitive Surgical Inc. VP Corporate Controller Fredrik Widman exercised 14 non-qualified stock options and sold 5,448 common shares on October 30, 2026. The option exercises covered 5,448 common shares, with exercise prices ranging from $79.6378 to $347.4167 per share; the sale price was a weighted average $436.0551 per share. The transactions took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1.
Insider Trade Summary 10b5-1
Exercise and Sale: 5,448 shares ($1.28M approx. pre-tax spread)
Exercise and Sale
29 txns
Insider
Widman Fredrik
Role
VP Corporate Controller
Sold
5,448 shs ($2.38M)
Approx. gross sale proceeds
$2.38M
Approx. exercise cost
$1.10M
Approx. pre-tax spread
$1.28M
Share of Position Sold
84.2%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F1, F3 | 546 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 543 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F3 | 325 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 262 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 325 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F5 | 567 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F3 | 263 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 312 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F6 | 307 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 567 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F5 | 406 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F5 | 312 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F7 | 307 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 406 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 546 | $79.6378 | $43K |
| Exercise | Common Stock F1 | 312 | $208.90 | $65K |
| Exercise | Common Stock F1 | 325 | $139.52 | $45K |
| Exercise | Common Stock F1 | 307 | $304.67 | $94K |
| Exercise | Common Stock F1 | 307 | $229.39 | $70K |
| Exercise | Common Stock F1 | 312 | $290.33 | $91K |
| Exercise | Common Stock F1 | 406 | $347.4167 | $141K |
| Exercise | Common Stock F1 | 406 | $245.60 | $100K |
| Exercise | Common Stock F1 | 567 | $242.3367 | $137K |
| Exercise | Common Stock F1 | 567 | $177.9867 | $101K |
| Exercise | Common Stock F1 | 262 | $166.6233 | $44K |
| Exercise | Common Stock F1 | 263 | $182.8333 | $48K |
| Exercise | Common Stock F1 | 325 | $174.2567 | $57K |
| Exercise | Common Stock F1 | 543 | $109.4856 | $59K |
| Sale | Common Stock F1, F2 | 5,448 | $436.0551 | $2.38M |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 6,188 contracts (Direct);
Common Stock — 1,026 shares (Direct)
Holdings Before and After:
Non-Qualified Stock Option (right to buy), 11,636 to 6,188 contracts (Direct);
Common Stock, 1,026 to 1,026 shares (Direct)
Other Insiders: 4 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (7)
- F1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $431.64 to $453.60 as follows: 2,650 shares sold at $431.64 to $432.57; 279 shares sold at $432.71 to $433.31; 239 shares sold at $433.85 to $434.35; 79 shares sold at $434.93 to $435.64; 321 shares sold at $435.93 to $436.73; 160 shares sold at $437.33 to $437.79; 480 shares sold at $438.76 to $439.62; 120 shares sold at $439.83 to $440.03; 160 shares sold at $440.89 to $441.86; 200 shares sold at $442.20 to $442.92; 200 shares sold at $443.37 to $444.14; 160 shares sold at $444.47 to $445.32; 240 shares sold at $445.73 to $446.59; 80 shares sold at $446.86 to $447.26; and 80 shares sold at $453.60. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range
- F3. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
- F4. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
- F5. Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
- F6. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
- F7. 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
Key Figures
Shares sold: 5,448 shares
Weighted average sale price: $436.0551 per share
Sale transaction price range: $431.64–$453.60 per share
+3 more
6 metrics
Shares sold
5,448 shares
October 30, 2026
Weighted average sale price
$436.0551 per share
Sale on October 30, 2026
Sale transaction price range
$431.64–$453.60 per share
Multiple transactions
Shares acquired through option exercises
5,448 shares
October 30, 2026
Option exercise price range
$79.6378–$347.4167 per share
Options exercised October 30, 2026
Trading Plan expiration
September 15, 2027
Trading Plan complying with SEC Rule 10b5-1
Key Terms
Non-Qualified Stock Option, weighted average sale price, Rule 10b5-1
3 terms
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
Rule 10b5-1 regulatory
"a Trading Plan that complies with SEC Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When does Fredrik Widman's ISRG trading plan expire?
The Trading Plan expires on September 15, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
